Federal contractor profile
SOLARIS VACCINES, INC.
UEI G1P5NEDCERA9CAGE 97FY7
Active
Overview
- Legal name
- SOLARIS VACCINES, INC.
- Registered location
- FORT COLLINS, CO, USA
- Primary NAICS
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Latest award activity
- Jun 4, 2026
Read company summary
SOLARIS VACCINES, INC. is associated with UEI G1P5NEDCERA9 and CAGE 97FY7 in public federal records. AcornBids currently links 2 prime awards totaling $1.5M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Defense. Its recorded federal awards include work classified as Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)). Its public SAM.gov registration lists FORT COLLINS, CO, USA.
At a glance
Lifetime prime obligations$1.5M
Prime awards2
Awards with future end dates1
Top-agency concentration
Not available
Why this customer concentration
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 27, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- SOLARIS VACCINES, INC.
- UEI
- G1P5NEDCERA9
- CAGE
- 97FY7
- Registered address
- 3185 RAMPART RD, FORT COLLINS, CO, 80521, USA
- Registration status
- Active
- Primary NAICS
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM activation
- Apr 30, 2026
- Initial registration
- Oct 15, 2021
- Entity start
- Aug 16, 2021
- SAM updated
- Apr 30, 2026
- Registration expires
- Apr 28, 2027
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| HT942525C0028DHA PHASE II SBIR CONTRACT FOR VACCIRAPTOR: HIGH-THROUGHPUT, CONTINUOUS FLOW-THROUGH SYSTEM FOR PSORALEN-UVA INACTIVATION | Department of Defense | $1.3M | Jul 2, 2025 | Nov 1, 2027 |
| HT942524P0078DHA SBIR PHASE I VACCIRAPTOR: HIGH-THROUGHPUT, CONTINUOUS FLOW-THROUGH DEVICE FOR PSORALEN-UVA INACTIVATION OF DENGUE VIRUS | Department of Defense | $249.7K | Jun 21, 2024 | Jan 20, 2025 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Apr 30, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Oct 15, 2021 |
| Entity start | Aug 16, 2021 |
| Industry | Reported size status |
|---|---|
| 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| MARK WAGSTAFF | Government business | Contact method not published | SAM registration | Not available |
| OLIVIA ASFAHA | Alternate government business | Contact method not published | SAM registration | Not available |
| MARK WAGSTAFF | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
376 awards
207 awards
147 awards
131 awards
119 awards
104 awards
About SOLARIS VACCINES, INC.
What products and services appear in its federal awards?
Recorded award industries: 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
Recorded products and services: AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH; AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH.
Examples from recent award records:
- DHA PHASE II SBIR CONTRACT FOR VACCIRAPTOR: HIGH-THROUGHPUT, CONTINUOUS FLOW-THROUGH SYSTEM FOR PSORALEN-UVA INACTIVATION
- DHA SBIR PHASE I VACCIRAPTOR: HIGH-THROUGHPUT, CONTINUOUS FLOW-THROUGH DEVICE FOR PSORALEN-UVA INACTIVATION OF DENGUE VIRUS
These records describe federal award work, not every company capability. Review the award evidence.
Where is the company registered?
3185 RAMPART RD, FORT COLLINS, Colorado 80521, United States
Registered location from SAM.gov; award performance locations may differ.
What is its primary registered industry?
Primary SAM.gov NAICS classification.
Which federal agencies are represented in its awards?
Department of Defense.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit